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Cardiac neural crest cells are essential for normal development of the great vessels and the heart, giving rise to a range of
cell types, including both neuronal and non-neuronal adventitial cells and smooth muscle. Endothelin (ET) signaling plays
an important role in the development of cardiac neural crest cell lineages, yet the underlying mechanisms that act to control
their migration, differentiation, and proliferation remain largely unclear. We examined the expression patterns of the
receptor, ETA, and the ET-specific converting enzyme, ECE-1, in the pharyngeal arches and great vessels of the developing
chick embryo. In situ hybridization analysis revealed that, while ETA is expressed in the pharyngeal arch mesenchyme,
populated by cardiac neural crest cells, ECE-1 expression is localized to the outermost ectodermal cells of the arches and
then to the innermost endothelial cells of the great vessels. This dynamic pattern of expression suggests that only a
subpopulation of neural crest cells in these regions is responsive to ET signaling at particular developmental time points.
To test this, retroviral gene delivery was used to constitutively express preproET-1, a precursor of mature ET-1 ligand, in
the cardiac neural crest. This resulted in a selective expansion of the outermost, adventitial cell population in the great
vessels. In contrast, neither differentiation nor proliferation of neural crest-derived smooth muscle cells was significantly
affected. These results suggest that constitutive expression of exogenous preproET-1 in the cardiac neural crest results in
expansion restricted to an adventitial cell population of the developing great vessels. © 2002 Elsevier Science (USA)
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The neural crest (NC) is a highly migratory cell popula-
tion arising from the dorsal region of the neural tube in
developing embryos around the time of neural tube closure
(Le Douarin, 1982). These cells migrate along a range of
specified pathways and differentiate into a wide variety of
cell types (Le Lie`vre and Le Douarin, 1975; Noden, 1975).
The cardiac NC is a unique subpopulation of the NC that
arises from the dorsal neural tube at the level between the
otic placode and the caudal boundary of somite 3 (Kirby et
al., 1983) and predominantly migrates into the pharyngeal
arches. As the lower arch arteries mature and become the
great vessels, cardiac NC cells differentiate into neuronal
and non-neuronal adventitial cells, as well as the majority
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All rights reserved.of the smooth muscle cells of the tunica media and mesen-
chymal cells necessary for septation of the outflow tract of
the heart (Le Lie`vre and Le Douarin, 1975; Kirby et al.,
1983; Bergwerff et al., 1998).
Cardiac NC cell development, including migration, pro-
liferation, differentiation, and survival, requires the assimi-
lation of a wide range of signals provided by both the cells
themselves and their environment (Kirby, 1999). Endothe-
lin (ET) is one of the paracrine factors implicated in cardiac
NC and great vessel development (Yanagisawa et al., 1988).
The ETs comprise a family of three isoforms, ET-1, -2, and
-3 (Inoue et al., 1989), that signal via two main classes of G
protein-coupled receptors, ETA and ETB (Arai et al., 1990;
Sakurai et al., 1990). The ET ligands are biologically inac-
tive until they undergo a two-step proteolytic processing
that involves conversion of preproendothelin (preproET) to
big-ET via nonspecific furin proteolysis, followed by cleav-To whom correspondence should be addressed. Fax: (212) 746-
age of big-ET to a mature biologically active ET peptide of
167
21 amino acids by endothelin-converting enzyme (ECE), a
type II membrane-bound metalloprotease (Xu et al., 1994;
Emoto and Yanagisawa, 1995).
Mutation or deletion of these ET-related genes gives rise
to developmental abnormalities, including defects in septa-
tion and remodeling of great vessels (Kurihara et al., 1994,
1995; Clouthier et al., 1998, 2000; Yanagisawa et al.,
1998a,b). The scope of the heart and great vessel phenotypes
largely overlaps with the typical anomalies seen upon
cardiac NC ablation (Bockman et al., 1987), suggesting that
cardiac NC cells are a target of ET signaling. In situ
hybridization studies in the developing mouse, and to a
lesser extent in the chick embryo, have revealed that
members of this gene family are expressed in a highly
dynamic manner, both spatially and temporally. ETA is
expressed by NC cells themselves, while preproET-1 and
ECE-1 are expressed by neighboring cell types (Nataf et al.,
1998; Kempf et al., 1998; Clouthier et al., 1998). Since
ECE-1 can convert bigET into biologically active ET both
intracellularly and extracellularly (Xu et al., 1994), it has
been suggested that a biologically active ligand is produced
which then signals via the ET receptor expressed by neigh-
boring cardiac NC cells (Yanagisawa et al., 1998a,b;
Clouthier et al., 1998). Thus, the differential expression of
the ET-signaling components may serve as a means to
direct NC cells to develop according to their spatial rela-
tionship to these factors. This hypothesis, however, re-
mains to be tested in a cardiac NC-specific manner. As
discussed by Kempf et al. (1998), previous targeted gene
inactivations (Kurihara et al., 1994; Clouthier et al., 1998;
Yanagisawa et al., 1998a,b) and pharmacological receptor
antagonism (Kempf et al., 1998) in the whole embryo do not
allow control of timing and location of signaling disruption.
The present study, therefore, employed the technique of
retroviral gene delivery, allowing us to modulate ET signal-
ing exclusively in cardiac NC cells and their progenitors.
Utilizing this approach, we examined the effect of consti-
tutive expression of exogenous preproET-1 on subsequent
pharyngeal arch and great vessel development during chick
embryogenesis. If the model is correct, upregulation of this
ET precursor must generate cell biological changes only in
a subset of great vessel cells, i.e., those adjacent to ECE-1
expression. Data are presented that show that ETA is
expressed predominantly in the mesenchyme of the pharyn-
geal arches, populated by cardiac neural crest cells, and
becomes down-regulated as the great vessels develop.
ECE-1 expression, however, is initially restricted to the
outer ectodermal layer of the arches, but as great vessel
development proceeds, shifts to the inner endothelial lining
of these vessels. Retroviral expression of exogenous
preproET-1 in cardiac NC gives rise to a significant expan-
sion of the adventitial cell population of the great vessels,
but not the medial smooth muscle cell population. Consis-
tent with the proposed model, our findings suggest that
exogenous preproET-1 expressed in the cardiac NC pre-
dominantly affects only a subpopulation of great vessel
cells, likely only those adjacent to ECE-1 expression which
is required for production of mature ET-ligand.
MATERIALS AND METHODS
In situ hybridization. DIG-labeled probes were generated from
linearized plasmids using standard riboprobe protocols, as de-
scribed previously (Takebayashi-Suzuki et al., 2000, 2001; Kan-
zawa et al., 2002). Whole embryos at embryonic day (E)4 and hearts
at E6 and E10 were fixed in 4% paraformaldehyde/phosphate-
buffered saline (PBS) overnight at 4°C and processed for whole-
mount in situ hybridization (Henrique et al., 1995), with a slight
modification as described (Takebayashi-Suzuki et al., 2000; Kan-
zawa et al., 2002). Some stained samples were refixed in 4%
paraformaldehyde and embedded in Paraplast (Oxford Labware,
MO) for histological sectioning.
Retroviral vectors. The CXL-virus, a replication-defective vari-
ant of spleen necrosis virus (SNV) encoding -galactosidase (-gal)
(Mikawa, 1995), was used as control. The CXIZppET virus
(Takebayashi-Suzuki et al., 2000) was used to coexpress the full
coding region of the human preproET-1 cDNA (Yanagisawa et al.,
1988) and -gal. Biological activities of CXIZppET virus, including
infectivity of chick embryonic cells and production of bigET by
infected cells, have been described elsewhere (Takebayashi-Suzuki
et al., 2000). Viral particles were concentrated to titers of the order
of 108 virions/ml. Propagation and viral concentration was con-
ducted as described elsewhere (Mima et al., 1995).
In ovo viral infection. Fertilized chicken eggs (Spafas, NJ or
Truslow Farms, MD) were incubated at 38°C under humidified
conditions until Hamburger and Hamilton stages (HH; Hamburger
and Hamilton, 1951) 8–11 (4–13 somite stage or approximately
38 h of incubation). A small hole was made in the eggshell.
Embryos were visualized by using neutral red-impregnated agar (10
mg neutral red/100 ml of 1% agarose) (Sigma, St. Louis, MO) placed
over the embryo on the amniotic membranes for 1–2 min and then
removed. Approximately 10 nl of concentrated viral solution
containing 100 g/ml polybrene (Sigma) was pressure-injected into
the neural folds of the neural tube, at the level between the otic
placode and the caudal boundary of the third somite of the embryo
using a Picospritzer (General Valve Co, NJ). Eggs were resealed
with Parafilm (American National Can, WI) and returned to the
incubator until various stages of development. Four hours prior to
harvest, a 25-l solution containing 75 g of BrdU (Amersham Life
Sciences, IL) was placed onto the amniotic membrane of infected
embryos.
Histochemistry and immunohistochemistry. Embryos or
hearts were isolated at various stages of development and fixed in
2% paraformaldehyde/PBS for 2–4 h at 4°C, rinsed three times in
PBS, and incubated overnight in a solution of 5-bromo-4-chloro-3-
indolyl- galactopyranoside (X-gal; Gold Biotechnology, Shelton
Scientific, CT) at 37°C. Samples with -gal-positive cells were
photographed, embedded in Paraplast, serially sectioned at 10 m
thickness, and examined. Sections were incubated with HNK-1
primary antibody (Sigma) specific for neural cell adhesion molecule
(N-CAM). Briefly, sections were dewaxed in Citrisolv (Fisher
Scientific, PA), rehydrated in an ethanol/H2O series, and washed in
PBS. Endogenous peroxidase activity was quenched by treatment
with 0.3% H2O2 and background was blocked with a solution of
0.1% Tween 20, 2% bovine serum albumin in PBS (PBT-BSA).
Sections were then incubated overnight in a 1:100 dilution of
HNK-1 antibody in PBT-BSA, rinsed in PBS, and incubated in a
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1:500 dilution of peroxidase-conjugated anti-mouse IgM secondary
antibody (Jackson Immunochemicals, PA). Immunoreactivity was
detected using 500 g/ml of diaminobenzidine and 0.003% H2O2 in
PBS. BrdU detection was performed as previously described using
monoclonal-BrdU antiserum, biotinylated anti-mouse IgG, and the
Vectastain Elite ABS kit for visualization (Lin et al., 2000). Detec-
tion of nuclei was performed by addition of a solution of 1 g/ml
DAPI (4,6-diamidino-2-phenylindole; Molecular Probes, Inc., OR)
in PBS to sections for 5 min at room temperature, followed by
rinsing in PBS.
TUNEL assay. Apoptotic cells were detected using the In Situ
Cell Death Detection Kit (Roche, Germany) according to the
method of Poelmann et al. (1998) with the following modifications:
the proteinase K step was omitted, slides were incubated in the
TUNEL reaction for 90 min at 37°C, and the signal conversion step
was performed for 45 min at 37°C.
Digital imaging and quantitative analysis. Images of embryos
and tissue sections were captured with either a Digital Photo
Camera (DKC-5000, Sony, Japan) or a Spot RT Slider (2.3.1,
Diagnostic Instruments Inc) and Adobe Photoshop (version 6.0,
Adobe Systems Inc., CA) or Spot (version 3.2.6 Diagnostic Instru-
ments Inc) software, respectively. All images were adjusted for
brightness and contrast and cropped in Adobe Photoshop 6.0. NIH
Image 1.62 software (National Institutes of Health) was used to
determine the area of various tissue layers in histological sections.
Cell density was expressed per unit area. Statistical analysis of data
were performed by using Student’s t test for unpaired samples.
RESULTS
Expression patterns of ETA and ECE-1 in the pharyngeal
arches and great vessels. In order to define the timing and
location at which cardiac NC cells are exposed to ET
signaling during pharyngeal arch and great vessel develop-
ment, the expression profiles of an ET receptor, ETA, and
converting enzyme, ECE-1, were examined. Whole-mount
in situ hybridization in the chick embryo revealed that ETA
receptor was expressed in the pharyngeal arches at E4 (Figs.
1A and 1B). At this time, cardiac NC cells are migrating
through pharyngeal arches 3, 4, and 6, but have not yet
reached the outflow tract of the heart (Waldo et al., 1998).
Sectioning of whole-mount in situ hybridization samples
demonstrated that ETA expression was localized to the
mesenchyme of these arches, adjacent to the aortic arch
arteries (Figs. 1C and 1D), the region populated by cardiac
neural crest cells (Le Lie`vre and Le Douarin, 1975;
Miyagawa-Tomita et al., 1991). By E10, ETA expression
became undetectable in either the endothelium, tunica
media, or adventitial cells of the great vessels (Figs. 1E and
1F), which developed from the aortic arch arteries of pha-
ryngeal arches 3, 4, and 6 (Le Lie`vre and Le Douarin, 1975).
These results show that ETA is expressed in the cardiac NC
cell population migrating through the pharyngeal arches,
but its expression is downregulated during the subsequent
development of the great vessels.
ECE-1 expression was detected in restricted regions of the
pharyngeal arches and developing great vessels throughout
this developmental window. Whole-mount analysis at E4
detected ECE-1 expression in the arches at slightly higher
levels than those broadly seen throughout embryos (Figs.
1G and 1H). Examination of sections revealed that ECE-1 is
preferentially expressed in the outer, ectodermal layer (Figs.
1I–1L). By E6, this expression in the outer layer was down-
regulated and instead was predominantly found in the
innermost, endothelial layer of the great vessels (not
shown). By E10, its expression in the great vessel endothe-
lium became more robust, at similar levels to that seen in
valve leaflets (Figs. 1M and 1N). At all stages examined, no
significant expression of ECE-1 was detected in cardiac
neural crest cells themselves in pharyngeal arch mesen-
chyme nor in the medial and adventitial cell layers of the
great vessels. These data show that while cardiac NC cells
express ETA receptor, they do not express ECE-1, essential
for production of biologically active ET ligand, at signifi-
cant levels. Since ECE-1 is preferentially expressed in the
ectoderm overlying cardiac NC cells, only an outer popula-
tion of cardiac NC cells may be exposed to production of
FIG. 1. ETA and ECE-1 expression in the developing pharyngeal arches and great vessels. In situ hybridization of E4 chick embryos
(A–D,G–L) and E10 embryonic hearts (E, F, M, N) with anti sense probes for ETA (A–C, E, F) and ECE-1 (G–K, M, N) and sense probes for
ETA (D) and ECE 1(L). (B, H) High-power views of the boxed areas in (A) and (G), respectively. (C, D, I–L) Sections of embryos after
whole-mount in situ hybridization (purple staining in ectoderm in C represents background signal, as seen in section in D after in situ
hybridization with ETA sense riboprobe). While ECE-1 is expressed in the ectoderm of the caudal pharyngeal arches (I), sections through the
same embryo demonstrate a lack of ectodermal expression overlying the neural tube (J) or in the anterior region of pharyngeal arch 1 (K).
h, heart; I, II, etc., first arch, second arch, etc.; *, lumen of aortic arch artery in (C), (D), (I), and (L), lumen of great vessel in (F) and (N); m,
mesenchyme; e, ectoderm; lv, left ventricle; rv, right ventricle; arrows, signal in pharyngeal arches in (B), (C), (H), and (I), valve leaflets in
(M).
FIG. 2. Constitutive preproET expression does not affect early cardiac neural crest development. (A) Proviral structures of CXL and
CXIZppET. Viral solution was injected into the neural folds of embryos between HH stages 8 and 11, between the otic placode and the
caudal boundary of somite 3, as indicated by asterisk. E4.5 embryos after infection with CXL (B–D) and CXIZppET (G–I). (C, H) Sections
through the pharyngeal arch region of infected embryos. (D, I) High-power views of the boxed areas in (C) and (H), respectively. At E6.5,
labeled cells were found in the developing great vessels and outflow tract region of the heart in both control (E) and CXIZppET-injected
embryos (J). Arrows in (E) and (J) correspond to levels of sections in (F) and (K), respectively. LTR, long terminal repeat; I, II, etc., first arch,
second arch, etc.; nt, neural tube; acv, anterior cardinal vein; da, dorsal aorta; pa, pulmonary artery; s, outflow tract septum.
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FIG. 3. Expansion of the great vessels by E9.5 in CXIZppET-infected embryos. Hearts of CXL- (A–D) and CXIZppET- (E–H) infected
embryos were examined in whole mount (A, E) and sections through the great vessels (B, C, F, G) and outflow tract (D, H). Arrows in (C)
and (G), infected adventitial cells. Magnification of images in (B) and (F), (C) and (G), and (D) and (H), respectively, are equal. Various levels
of adventitial cell infection were observed. (I) The ratio of the thickness of the adventitia to that of the tunica media was compared for each
of the great vessels at two planes of section: proximally, at the level of the aorticopulmonary septum (indicated by arrows labeled c and f),
and more distally (indicated by arrows labeled b and e). Measurements were taken from five sections at both proximal and distal levels for
4 CXL- and 3 CXIZppET-infected embryos. Bars indicate standard deviation from the mean. (J) The ratio of adventitial thickness to tunica
media thickness with increasing viral infection. rv, right ventricle; lv, left ventricle; ao, aorta; pa, pulmonary artery; rba, right
brachiocephalic artery; lba, left brachiocephalic artery; rpa, right pulmonary artery; lpa, left pulmonary artery; tm, tunica media; adv,
adventitia; *, P  0.01; **, P  0.001.
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mature ET ligand during pharyngeal arch and great vessel
development.
Retroviral targeting of the cardiac neural crest. To test
whether all or only a subpopulation of cardiac NC cells are
susceptible to ET signaling during pharyngeal arch and
great vessel development, preproET, the precursor of ma-
ture ET-1, was overexpressed in the cardiac NC. A
replication-incompetent retrovirus co-encoding preproET-1
and -gal (CXIZppET-virus; Takebayashi-Suzuki et al.,
2000) was injected into the neural folds at levels between
the otic placode and the caudal boundary of somite 3, the
region from which cardiac NC cells migrate, between stages
8 and 11 (Fig. 2A). We have previously reported that 1 ng
of bigET-1 is secreted from 106 cells infected with
CXIZppET-virus per day, but no processed active ET-1 is
secreted (Takebayashi-Suzuki et al., 2000). A virus encod-
ing the -gal gene alone (CXL-virus) was used as a control.
The resulting embryos were then examined at certain time
points after reincubation.
To ensure that a gene delivery by viral infection was
specific to the cardiac NC population, the distribution of
daughter cells infected with control, CXL-virus, was exam-
ined in embryos at E4.5, 3 days after injection. Whole-
mount X-gal staining for -gal revealed that the progeny of
infected cells were located dorsolaterally at the level of the
pharyngeal arches and more ventrally in arches 3, 4, and 6
(Fig. 2B). Histological sections of these embryos showed
-gal cells in the mesenchyme surrounding the aortic arch
arteries (Figs. 2C and 2D), consistent with the pathways
characteristic of cardiac NC migration at this stage (Le
Lie`vre and Le Douarin, 1975). Furthermore, immunohisto-
chemistry with HNK-1 antibody, a marker of NC cells,
revealed colocalization of this signal with many infected
cells (data not shown).
At E6.5, as the great vessels are developing from the
pharyngeal arches, -gal cells were found in these vessels
(Fig. 2E). A significant population of cardiac NC cells was
already distributed in the outflow tract of the heart, where
they facilitate its septation (Kirby et al., 1983). Histological
section examination revealed -gal cells in the mesen-
chyme of the developing great vessels and more proximally
in the central mesenchymal core of cells forming the
outflow tract septum that separates this single vessel into
the aorta and pulmonary trunk (Fig. 2F). A significant
number of labeled cells reached semilunar valve level and
were contributing to this septation. These results strongly
suggest that cardiac NC cells were successfully targeted by
retroviral infection at or prior to their migration out of the
neural tube. Importantly, the data also demonstrate that a
virally introduced exogenous gene can be expressed consti-
tutively and restrictively in infected cardiac NC during
pharyngeal arch and great vessel development.
Constitutive expression of preproET-1 does not affect
early cardiac NC migration. The same distribution pat-
tern of -gal cells was obtained in embryos infected with
CXIZppET virus. At E4.5, CXIZppET-infected embryos
exhibited -gal cells dorsolaterally at the level of the
arches and also within arches 3, 4, and 6 (Fig. 2G). In
histological section, -gal cells were seen migrating
through the mesenchyme surrounding the aortic arch arter-
ies (Figs. 2H and 2I). No detectable morphological defects
were seen in CXIZppET-infected embryos at this stage. At
E6.5, -gal cells were found in the great vessels and the
outflow tract of the heart (Fig. 2J), as seen in control
embryos. In section, CXIZppET-infected cardiac NC cells
were distributed in the same regions as those infected with
control CXL virus (Fig. 2K). Overexpression of preproET-1
in the cardiac NC therefore appeared to have no significant
effect on early migration of these cells, in terms of their
general pathway of migration and the timing of migration
to their most distant sites.
Expansion of the great vessels by exogenous preproET-1
at midgestation. In contrast to effects seen at E4 and E6.5,
CXIZppET-infected embryos exhibited a significant expan-
sion of the great vessels at E9.5 (Fig. 3). By this time, the
great vessels are well developed and outflow tract septation
is complete. At this stage, CXL-infected embryos exhibit
many -gal cells in the great vessels (Fig. 3A). In sections,
many of these cells were found in the tunica media layer of
the vessels, with fewer also found in the thinner adventitial
cell layer at both proximal and distal levels (Figs. 3B–3D).
Similarly, CXIZppET-infected embryos showed significant
labeling in the great vessels and outflow tract of the heart
(Figs. 3E–3H). Strikingly, however, the great vessels of these
embryos appeared to be significantly larger than in controls
(Fig. 3E). Upon sectioning, it was revealed that the increase
in thickness of these vessels was mainly due to an expan-
sion in size of the adventitia of these vessels, while the
thickness of the tunica intima and media layers remained
comparable to controls (Figs. 3F–3H). This adventitial ex-
pansion was observed both proximally and distally.
The degree of expansion of the adventitia for each of the
vessels was examined at two planes of section: proximally,
at the level of the aorta and pulmonary artery, and more
distally, where these two vessels have branched into five
vessels (the left and right pulmonary artery, left and right
FIG. 4. Cell density and neuronal differentiation in the adventitia. Using sections through the great vessels of E9.5 embryos infected with
CXL (A) and CXIZppET (B), cell density in the adventitial layer of the great vessels was analyzed by quantifying the number of
DAPI-positive nuclei per unit area (C). One section through a distal region of the great vessels of three different embryos was examined per
group. In each section, nuclei in the adventitial layer surrounding all five vessels were examined. Bars indicate standard deviation from the
mean. HNK-1 immunostaining was performed on sections of E6.5 embryos after earlier infection with CXL (D) and CXIZppET (E) infection.
Arrows, HNK-1-positive neuronal bundles.
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brachiocephalic arteries and the aorta) (Fig. 3I). In all vessels
of embryos infected with CXIZppET, a similar degree of
expansion was scored at both proximal and distal levels,
compared with controls (Fig. 3I). Furthermore, the degree of
adventitial expansion was dependent on the level of infec-
tion (Fig. 3J). With increased CXIZppET infection of the
cardiac NC population, there was a concomitant increase in
the expansion of the adventitial layer of the great vessels,
while the level of infection of cardiac neural crest cells with
CXL had no effect on expansion of the adventitia (Fig. 3J).
These results show that infection of cardiac NC with
CXIZppET virus gives rise to a significant expansion of the
great vessel adventitia, but not the tunica media or intima,
in a dose-dependent manner.
Expansion of the adventitia is due to increased cell
number rather than hypertrophy. The increase in adven-
titial thickness of the great vessels upon upregulation of
preproET expression may result from several mechanisms,
such as adventitial cell hypertrophy, increased cell prolif-
eration, and/or promotion of cell survival. Furthermore,
this expansion may be a result of differential development
of either of two cardiac NC cell populations found in this
cell layer: neuronal cells or non-neuronal mesenchymal
cells. The potential effects of upregulated ET signaling on
these cell biological events were examined during cardiac
NC development.
The changes in cell number and cell size were analyzed
by scoring the number and density of cell nuclei in the great
vessel adventitia of embryos at E9.5 (Figs. 4A–4C). A
comparison of the number of nuclei per unit area in the
adventitial layers of control and CXIZppET-infected
samples revealed a slightly higher cell density in
CXIZppET-injected embryos, though this was not statisti-
cally significant (Fig. 4C). Since the number of cells per unit
area was comparable in both groups, but the total area of the
adventitia is increased in CXIZppET-infected samples com-
pared with controls, the mechanism for this adventitial
expansion is clearly due to increased cell number, rather
than cellular hypertrophy.
As adventitial cell expansion was observed at midgesta-
tion, the cellular mechanisms that give rise to this expan-
sion must occur prior to this time point. We therefore
examined injected embryos at E6.5. To examine whether
the expansion of the adventitia was largely due to neuronal
cells or non-neuronal mesenchymal cells, immunohisto-
chemistry was performed on sections of E6.5 embryos,
using the HNK-1 antibody, a marker of neuronal cell
populations (Tucker et al., 1988). The distribution of neu-
ronal bundles in the adventitia of the vessels was compa-
rable in both control and CXIZppET-infected samples (Figs.
4D and 4E), suggesting that overexpression of preproET
does not significantly promote changes in the neuronal cell
population. The expansion of the adventitial layer therefore
appears to be due to an increase in the number of non-
neuronal cells.
Cell survival is modulated by overexpression of
preproET-1. To examine potential mechanisms by which
expansion of adventitial cell number in CXIZppET-infected
embryos arises, E6.5 embryos were analyzed for levels of
cell proliferation and programmed cell death. BrdU incor-
poration was analyzed by using transverse sections from the
region of the forming outflow tract septum as well as at a
more distal level of the great vessels for this analysis (Figs.
5A and 5B). Interestingly, BrdU incorporation levels ap-
peared to be much higher in the lateral walls of the outflow
tract, in contrast to low levels of proliferation in the central
mesenchymal core of the forming outflow septum. Almost
no BrdU cells were detected in the myocardialized region
of the outflow tract (Figs. 5A and 5B). On average, the
number of BrdU cells was approximately 3,100 cells/mm2
in control and 3,500 cells/mm2 in CXIZppET-infected em-
bryos at proximal levels. Distally, more variation was seen
in both control- and CXIZppET-infected embryos. How-
ever, in both cases no statistically significant difference was
detected.
Apoptosis was analyzed in regions of the outflow tract
and great vessels by TUNEL assay (Figs. 5D–5F). At proxi-
mal levels, 98 TUNEL cells/mm2 were detected in control
embryos on average, while 64 cells/mm2 were found in
CXIZppET-infected samples, representing a decrease of
35% in levels of apoptosis. At distal levels, more apoptotic
cells were detected (Fig. 5F). However, levels of apoptosis
were more variable between samples and no significant
difference was seen between control and CXIZ-ppET-
infected embryos. These results show that a significant
decrease in the numbers of cells undergoing apoptosis in the
outflow region of the heart at E6.5 in CXIZppET-infected
embryos, compared with controls. Thus, adventitial cells of
the outflow tract are susceptible to preproET-1 overexpres-
sion, resulting in decreased levels of apoptosis. Together
with a slight increase in the number of BrdU cells,
overexpression of preproET-1 appears to increase adventi-
tial cell number via promotion of cell proliferation and/or
survival of NC-derived adventitial cells in this region.
DISCUSSION
The current study has examined the potential role of ET
signaling in the development of the cardiac NC population,
during its migration from the neural tube to the pharyngeal
arches and during subsequent great vessel development. In
particular, we have tested the model that the dynamic and
distinct expression patterns of ET signaling components in
pharyngeal arches and developing great vessels may define
differential susceptibility among migrating cardiac NC
cells to this signaling and thus affect their subsequent
development. We demonstrate for the first time that exog-
enous gene expression can be induced restrictively to the
cardiac NC by a retroviral-mediated gene transfer tech-
nique, resulting in modulation of cardiac NC cell behavior.
Our data show that constitutive expression of the ET-1
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precursor, preproET-1, in the cardiac NC does not affect
early development of the pharyngeal arches or great vessels,
but by midgestation results in an expansion of the adven-
titial cell population of the great vessels. In contrast, no
significant expansion was seen in the tunica media layer of
the great vessels, the major cardiac NC-derived population
here, suggesting independent susceptibility of development
of the smooth muscle and adventitial cell lineages to
ET-signaling in vivo. Thus, supporting the proposed model
(Yanagisawa et al., 1998a,b), our data suggest that the
temporal and spatial patterns of expression of ET signaling
components may be involved in this differential response of
cardiac NC lineages to the exogenous preproET-1.
The expression pattern of the receptor ETA is well docu-
mented during pharyngeal arch development in avian spe-
cies (Nataf et al., 1998; Kempf et al., 1998), yet the expres-
sion profile of the converting enzyme, ECE-1, has received
little attention. Furthermore, the patterns of expression of
ET signaling factors in the great vessels have yet to be
sufficiently addressed, despite the fact that ET signaling is
essential for correct morphogenesis and maintenance of
these vessels. In the mouse, it has been suggested that
restricted expression of preproET-1 in the pharyngeal
arches, complimentary to ETA expression by NC cells, may
set up a “microenvironmental signal,” directing arch artery
remodeling (Yanagisawa et al., 1998a,b; Clouthier et al.,
1998). In the absence of ETA production, arch artery devel-
opment is defective (Clouthier et al., 1998; Kempf et al.,
1998). Since preproET-1 mRNA expression in the pharyn-
geal arches of the chick is widespread, located in the
mesodermal core of the arches as well as the endoderm and
ectoderm (Nataf et al., 1998), it is unlikely that this factor
acts as a spatial regulator of ET signaling. Importantly,
however, our analysis of ECE-1 expression suggests that
this component of the ET signaling may establish a similar
“microenvironment” in the chick. ETA mRNA is expressed
in the arch mesenchyme, populated by cardiac NC cells
(Nataf et al., 1998; Kempf et al., 1998). We have shown that
ECE-1, in contrast, is largely excluded from this region and
is restricted to the overlying ectoderm. Together with the
fact that mature ET-1 ligand is known to act only over short
distances (Yanagisawa, 1994), it is likely that ET signaling
will occur only in the outer region of the pharyngeal arches,
in which expression of ECE-1 is apposed to that of ETA.
Consistent with this idea, our data suggest that only the
cell population adjacent to ECE-1 expression in the pharyn-
geal arches is affected by the introduction of exogenous
preproET-1 to the cardiac NC.
Since ET is thought to act in a paracrine manner, it is
possible that upregulated ET signaling in the vicinity of
CXIZppET-infected cells may act to promote cell biological
changes in neighboring cells, or stimulate recruitment of
fibroblasts to the adventitia. However, except for cardiac
neurons, little is known about the ontogeny of adventitial
cells of the great vessels. It has been suggested that pericar-
dial villi found in human and rabbit embryos near the aortic
sac may contribute cells to the adventitia, yet there is no
direct evidence for this to date (Ma¨nner et al., 2001). Our
data now show that NC cells generate both neuronal and
non-neuronal adventitial cells of the great vessels. How-
ever, since our retroviral infection tagged only a portion of
FIG. 5. Adventitial cell survival is modulated by overexpression of preproET-1 in the cardiac neural crest. Transverse sections at the level
of the aorticopulmonary septum as well as at a more distal level of the great vessels were analyzed for BrdU incorporation to assess relative
levels of cell proliferation (A–C) and cell death using TUNEL assay (D–F) at E6.5. (A) Section of outflow tract of CXL-infected embryo. (B)
Section through outflow tract of CXIZppET-infected embryo. At each level, one section was analyzed per embryo; three embryos were
analyzed per group. (D) Section of outflow tract of CXL-infected embryo. (E) Section of outflow tract of CXIZppET infected embryo. At each
level, two to four sections were analyzed per embryo; three to four embryos were analyzed per group. Bars indicate standard deviation from
the mean. ao, aorta; pa, pulmonary artery; s, outflow tract septum; arrows, TUNEL-positive cells; *, P  0.05.
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cardiac NC cells, it remains to be determined whether all
adventitial cells are derived from the cardiac NC.
Our data clearly show an expansion of the great vessel
adventitia resulting from infection of the cardiac NC with
preproET-producing virus. We have previously shown that
1 ng of bigET-1 is secreted from 106 cells infected with
CXIZppET virus per day, while no active ET-1 is secreted
(Takebayashi-Suzuki et al., 2000). Furthermore, our previ-
ous study utilizing the CXIZppET retrovirus to ectopically
induce ET production has demonstrated localized biological
activity at sites of overlapping preproET and ECE-1 expres-
sion (Takebayashi-Suzuki et al., 2000). Based on these
experiments and the expansion of the adventitia observed
in the current study upon infection with the preproET-
expressing retrovirus but not the control virus, it is likely
that biologically active ET ligand is produced at sites of
apposing preproET and ECE-1 expression. While ET anti-
bodies have been used for ELISA analysis of ET levels
(Suzuki et al., 1989), such antibodies have not been success-
ful in the elucidation of spatial expression patterns of this
protein in our hand. Thus, the exact level of ectopic ET
ligand in the infected embryos remains to be established.
A specific mechanism underlying preproET-induced ex-
pansion of the great vessel adventitia has yet to be deduced.
However, upregulated ET signaling in the already well-
developed great vessels may be ruled out since ETA is not
expressed in this region. Consistent with this idea, our data
show that, despite a high level of ECE-1 expression in the
intimal layer at this stage, exogenous preproET-1 expres-
sion does not significantly affect development of the adja-
cent tunica media. Although ET-signaling can act as a
mitogen for adult vascular smooth muscle cells in culture
(Alberts et al., 1994; Weber et al., 1994; Damon, 2000), cells
in the tunica media of embryonic great vessels, where ETA
is already downregulated, do not appear to be sensitive to
exogenous preproET-1 expression. Furthermore, it has been
demonstrated that the sensitivity of neural crest cells to
pharmacological disruption of ETA signaling in the pharyn-
geal arches is restricted to a period between E3 and E4
(Kempf et al., 1998). ETA blockade at this time point results
in subsequent craniofacial as well as aortic arch defects, at
much later time points, suggesting a delay in the onset of a
phenotype upon alteration of ET signaling. Alternatively,
selective adventitial expansion may reflect the fact that the
adventitia of major vessels is the first tissue layer to
respond to pathological stimuli such as hypoxia, as tested in
a number of model systems (Das et al., 2002; reviewed in
Stenmark and Mecham, 1997). This results in adventitial
thickening, often as a result of increased cell proliferation
or matrix deposition. In our in vivo system, despite high
levels of exogenous preproET expression in the tunica
media of the great vessels, a response may be seen in the
adventitial layer due to the greater susceptibility of this
tissue to external stimuli.
The idea that an activation site of ET-signaling is defined,
spatially and temporally, by the expression of ECE-1 and
ET-receptors is also supported by normal early migration of
cardiac NC cells and pharyngeal arch formation in the
preproET virus-infected chick embryos. In the mouse, ETA
is expressed as soon as neural crest cells leave the neural
tube, yet in the chick, ETA is not expressed by NC cells
until they reach the arches at E3 (Nataf et al., 1998). It is
therefore not surprising that there is little effect on pharyn-
geal arch development upon increased expression of
preproET-1 in pre- and early migratory cardiac neural crest
cells in the chick. Furthermore, ablation of the cardiac
neural crest in the chick has shown that the arch arteries
can form in the absence of the neural crest, but NC cells are
required at later stages for maintenance of the vessels
(Waldo et al., 1996). Complimentary to this, gene inactiva-
tion of ETA, preproET-1 or ECE-1 in the mouse does not
affect early migration of cardiac NC cells and formation of
the pharyngeal arches (Yanagisawa et al., 1998a; Clouthier
et al., 2000).
In vitro studies have shown that exogenous ET ligands
can promote selective proliferation and/or survival of spe-
cific neural crest cell lineages (Lahav et al., 1996; Opde-
camp et al., 1998; Wu et al., 1999). Temporal and spatial
distributions of apoptosis within the heart have been exten-
sively studied (Pexieder, 1975; Manasek, 1969; Poelmann et
al., 1998; Watanabe et al., 1998; Cheng et al., 2002). These
studies have highlighted foci of apoptotic cells in areas such
as the outflow tract cushions, atrioventricular cushions
and, at late stages of development, smooth muscle cells of
the great vessels. In preproET-1 virus-infected embryos, we
observed a significant decrease in cell death in the outflow
tract, compared to controls. Complimentary to these find-
ings, it has been shown in ETA-deficient mouse embryos,
levels of apoptosis increased by almost fourfold in the
pharyngeal arches (Clouthier et al., 2000). In our study, it
seems that upregulated ET signaling in a subpopulation of
the cardiac NC selectively promotes their survival in the
developing arch arteries, resulting in expansion of the great
vessel adventitia later in development. This idea is consis-
tent with the fact that infection of only a small population
of adventitial cells with preproET-1 virus gives rise to a
uniform, circumferential expansion of the adventitia seen
at E9.5. It remains to be determined over what distance a
paracrine effect of preproET-1 virus infected cells may act
on neighboring cells and control their survival.
Studies of modifications in vessel morphology and physi-
ology following injury or hemodynamic changes demon-
strate that all three tissue layers of blood vessels (the
intima, tunica media, and adventitia) are capable of consid-
erable remodeling, involving dynamic changes in levels of
apoptosis and cell proliferation (Kalra and Miller, 2000).
Since ET is a potent vasoconstrictor, upregulation of ET in
the developing great vessels may generate physiological
changes to which the adventitial cells of these vessels
respond. Removal of adventitial cells from large arteries
results in changes in the response of these vessels to
neurotransmitter-induced contraction and relaxation
(Gonzalez et al., 2001), indicating that the adventitia may
play a role in the contractile capacity of vessels, as well as
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a supportive role for the inner tissue layers of the vessels
and their neuronal cells.
Our data provide further insight into the mechanisms by
which ET signaling acts on the cardiac neural crest to
regulate development of the great vessels. Our data are
consistent with the model that ET acts on postmigratory
cardiac neural crest cells and is involved in selective sur-
vival of particular neural crest-derived cell lineages. A range
of approaches has been employed to target the neural crest
population (Poelmann et al., 1998; Lo et al., 1997; Li et al.,
1999). Here, we have demonstrated for the first time the
ability to exclusively target the cardiac neural crest popu-
lation for retroviral-mediated exogenous gene delivery. This
technology represents a novel approach to the study of the
cardiac NC, allowing the modulation of signaling events
specifically in the great vessels and outflow tract of the
heart. Genetic mutations in the mouse embryo have pro-
vided valuable evidence for the importance of particular
genes in cardiac NC development. However, the global
disruption of such genes has often made the findings of
these approaches difficult to interpret. The use of retroviral-
mediated gene transfer allows us to perform more subtle
perturbations of the cardiac NC population that can be
controlled both spatially and temporally, thereby comple-
menting the mouse knockout system and bridging the gap
between this approach and the in vitro study of neural crest
cells.
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